Research and innovation in machine learning in the pharmaceutical sector is on the rise.
The most recent figures show that the number of related patent applications in the industry stood at 77 in the three months ending March – up from 66 over the same period in 2021.
Figures for patent grants related to followed a similar pattern to filings – growing from three in the three months ending March 2021 to eight in the same period in 2022.
Machine learning related innovation in the pharmaceutical industry has increased in the last three months
Number of related patents and grants linked to pharmaceutical companies, by three-month period:
The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.
is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.
The figures also provide an insight into the largest innovators in the sector.
Johnson & Johnson was the top innovator in the pharmaceutical sector in the latest quarter. The company, which has its headquarters in the United States, filed 31 related patents in the three months ending March. That was up from 11 over the same period in 2021.
It was followed by the Switzerland based F. Hoffmann-La Roche Ltd with 15 patent applications, Germany based Bayer AG (8 applications), and the United States based Pfizer Inc (5 applications).
Who are the top related innovators in the pharmaceutical industry?
Number of related patent applications linked to key companies in the three months ending March.
Johnson & Johnson has recently ramped up R&D in machine learning. It saw growth of 64.5% in related patent applications in the three months ending March compared to the same period in 2021 - the highest percentage growth out of all companies tracked with more than 10 quarterly patents in the pharmaceutical sector.
